Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy

NCT02400866 is registered in ClinicalTrials.gov with Korean South West Oncology Group as lead sponsor.

NCT NCT02400866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02400866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy
Lead sponsor
Korean South West Oncology Group
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2015
Completion date
April 30, 2017
Enrollment
58 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer